A short survey on selected β-galactosidase inhibitors as potential pharmacological chaperones for G -gangliosidosis and Morquio B associated mutants of human lysosomal β-galactosidase is provided highlighting recent developments in this particular area of lysosomal storage disorders and orphan diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/tcr.202100269 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!